Africa’s bid to make 60% of its vaccines by 2040 faces hurdles

Science reports that Africa’s effort to make most of its own vaccines by 2040 faces significant financial and logistical challenges. It points to struggles at South African companies while questioning whether the continent can reach 60% by then.